GlassScriptPhysician profile
Bernard S Kim
NPI 1184723231
$9,467.45
in general payments reported to CMS, 2019-2025
35 companies · $2,276 in 2025
The $2,276 reported for 2025 was more than what 78% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $721 · 2020: $668 · 2021: $729 · 2022: $1,075 · 2023: $1,645 · 2024: $2,353 · 2025: $2,276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,193 · Education: $80.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,192.97 |
| Education | $80.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,201.02 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,676.96 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| Glaxosmithkline, LLC. | $1,416.49 | 2020-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Insmed, INC. | $465.24 | 2022-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $414.30 | 2022-2025 | Dupixent |
| Pfizer INC. | $325.13 | 2019-2021 | |
| Mylan Specialty L.P. | $239.71 | 2019-2024 | Yupelri |
| Genzyme Corporation | $229.56 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $225.93 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Grifols USA, LLC | $224.67 | 2019-2024 | Prolastin-C Liquid |
| Advanced Respiratory, INC | $203.87 | 2019-2021 | |
| Electromed, INC. | $190.23 | 2024-2025 | Smartvest |
| Gilead Sciences, INC. | $166.57 | 2021-2024 | |
| Philips North America LLC | $145.26 | 2022-2025 | (Ak6) Vest Therapy, Disposable Vest |
| Genentech USA, INC. | $137.93 | 2019-2023 | Xolair |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $133.82 | 2021-2023 | Acthar |
| Viatris Specialty LLC | $123.69 | 2025 | Yupelri |
| Baxter Healthcare | $122.43 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Actelion Pharmaceuticals US, INC. | $113.71 | 2020-2024 | Uptravi, Opsumit |
| Janssen Pharmaceuticals, INC | $90.41 | 2022-2024 | Xarelto |
| Verona Pharma, INC. | $85.54 | 2025 | Ohtuvayre |
| Pulmonx Corporation | $69.02 | 2020-2025 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Ani Pharmaceuticals, INC. | $58.12 | 2025 | Purified Cortrophin Gel |
| E.R. Squibb & Sons, L.L.C. | $55.05 | 2020-2023 | Opdualag |
| Celgene Corporation | $49.74 | 2022 | |
| Shionogi INC | $45.19 | 2021-2023 | Fetroja |
| Bayer Healthcare Pharmaceuticals INC. | $43.82 | 2020-2024 | |
| Paratek Pharmaceuticals, INC. | $40.81 | 2023-2024 | Nuzyra |
| Intuitive Surgical, INC. | $30.62 | 2024 | |
| Portola Pharmaceuticals, LLC | $27.87 | 2019 | |
| Abbvie INC. | $27.19 | 2022 | |
| La Jolla Pharmaceutical Company | $26.21 | 2023 | Giapreza |
| Allergan, INC. | $24.69 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $23.67 | 2019 | |
| Carestream Dental, LLC | $12.98 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.